Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

A new compound effectively inhibits human 5α-reductase 1.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Targeting NETs may help reduce fibrosis in Crohn's disease.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

M50054 may help treat hepatitis and hair loss from chemotherapy.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

CBD can either promote or inhibit hair growth depending on the concentration used.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.